• レポートコード:MRC2102QY9927 • 出版社/出版日: / 2021年1月 • レポート形態:英文、PDF、133ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の眼用ドラッグデリバリー市場について種類別(接眼レンズ、イオントフォレーシス、眼内インプラント、insituジェル&涙点プラグ、その他)、用途別(病院、外来手術センター、眼科クリニック、在宅医療施設)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・眼用ドラッグデリバリー市場の概要 ・世界の主要地域別眼用ドラッグデリバリー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の眼用ドラッグデリバリー市場規模2015-2026:種類別(接眼レンズ、イオントフォレーシス、眼内インプラント、insituジェル&涙点プラグ、その他) ・世界の眼用ドラッグデリバリー市場規模2015-2026:用途別(病院、外来手術センター、眼科クリニック、在宅医療施設) ・眼用ドラッグデリバリーの米国市場規模2015-2020 ・眼用ドラッグデリバリーのヨーロッパ市場規模2015-2020 ・眼用ドラッグデリバリーの中国市場規模2015-2020 ・眼用ドラッグデリバリーの日本市場規模2015-2020 ・眼用ドラッグデリバリーの東南アジア市場規模2015-2020 ・眼用ドラッグデリバリーのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・眼用ドラッグデリバリーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・眼用ドラッグデリバリーの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Ocular Drug Delivery Market
The global Ocular Drug Delivery market size is projected to reach US$ 33610 million by 2026, from US$ 25430 million in 2020, at a CAGR of 4.8% during 2021-2026.
Global Ocular Drug Delivery Scope and Market Size
The global Ocular Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Ocular Drug Delivery market is segmented into
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Segment by Application, the Ocular Drug Delivery market is segmented into
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
The Ocular Drug Delivery market is analysed and market size information is provided by regions (countries). Segment by Application, the Ocular Drug Delivery market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ocular Drug Delivery Market Share Analysis
Ocular Drug Delivery market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ocular Drug Delivery business, the date to enter into the Ocular Drug Delivery market, Ocular Drug Delivery product introduction, recent developments, etc.
The major vendors covered:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
1 Ocular Drug Delivery Market Overview
1.1 Ocular Drug Delivery Product Scope
1.2 Ocular Drug Delivery Segment by Type
1.2.1 Global Ocular Drug Delivery Sales by Type (2020-2026)
1.2.2 Ocular Insert
1.2.3 Iontophoresis
1.2.4 Intraocular Implants
1.2.5 In Situ Gel & Punctal Plugs
1.2.6 Others
1.3 Ocular Drug Delivery Segment by Application
1.3.1 Global Ocular Drug Delivery Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Ophthalmic Clinics
1.3.5 Homecare Settings
1.4 Ocular Drug Delivery Market Estimates and Forecasts (2015-2026)
1.4.1 Global Ocular Drug Delivery Sales Growth Rate (2015-2026)
1.4.2 Global Ocular Drug Delivery Revenue and Growth Rate (2015-2026)
1.4.3 Global Ocular Drug Delivery Price Trends (2015-2026)
2 Ocular Drug Delivery Estimate and Forecast by Region
2.1 Global Ocular Drug Delivery Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Ocular Drug Delivery Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Ocular Drug Delivery Sales Market Share by Region (2015-2020)
2.2.2 Global Ocular Drug Delivery Revenue Market Share by Region (2015-2020)
2.3 Global Ocular Drug Delivery Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Ocular Drug Delivery Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Ocular Drug Delivery Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Ocular Drug Delivery Estimates and Projections (2015-2026)
2.4.2 Europe Ocular Drug Delivery Estimates and Projections (2015-2026)
2.4.3 China Ocular Drug Delivery Estimates and Projections (2015-2026)
2.4.4 Japan Ocular Drug Delivery Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Ocular Drug Delivery Estimates and Projections (2015-2026)
2.4.6 India Ocular Drug Delivery Estimates and Projections (2015-2026)
3 Global Ocular Drug Delivery Competition Landscape by Players
3.1 Global Top Ocular Drug Delivery Players by Sales (2015-2020)
3.2 Global Top Ocular Drug Delivery Players by Revenue (2015-2020)
3.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Drug Delivery as of 2019)
3.4 Global Ocular Drug Delivery Average Price by Company (2015-2020)
3.5 Manufacturers Ocular Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Ocular Drug Delivery Players (Opinion Leaders)
4 Global Ocular Drug Delivery Market Size by Type
4.1 Global Ocular Drug Delivery Historic Market Review by Type (2015-2020)
4.1.1 Global Ocular Drug Delivery Sales Market Share by Type (2015-2020)
4.1.2 Global Ocular Drug Delivery Revenue Market Share by Type (2015-2020)
4.1.3 Global Ocular Drug Delivery Price by Type (2015-2020)
4.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Global Ocular Drug Delivery Price Forecast by Type (2021-2026)
5 Global Ocular Drug Delivery Market Size by Application
5.1 Global Ocular Drug Delivery Historic Market Review by Application (2015-2020)
5.1.1 Global Ocular Drug Delivery Sales Market Share by Application (2015-2020)
5.1.2 Global Ocular Drug Delivery Revenue Market Share by Application (2015-2020)
5.1.3 Global Ocular Drug Delivery Price by Application (2015-2020)
5.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2021-2026)
6 United States Ocular Drug Delivery Market Facts & Figures
6.1 United States Ocular Drug Delivery Sales Market Share by Company (2015-2020)
6.2 United States Ocular Drug Delivery Sales Market Share by Type (2015-2020)
6.3 United States Ocular Drug Delivery Sales Market Share by Application (2015-2020)
7 Europe Ocular Drug Delivery Market Facts & Figures
7.1 Europe Ocular Drug Delivery Sales Market Share by Company (2015-2020)
7.2 Europe Ocular Drug Delivery Sales Market Share by Type (2015-2020)
7.3 Europe Ocular Drug Delivery Sales Market Share by Application (2015-2020)
8 China Ocular Drug Delivery Market Facts & Figures
8.1 China Ocular Drug Delivery Sales Market Share by Company (2015-2020)
8.2 China Ocular Drug Delivery Sales Market Share by Type (2015-2020)
8.3 China Ocular Drug Delivery Sales Market Share by Application (2015-2020)
9 Japan Ocular Drug Delivery Market Facts & Figures
9.1 Japan Ocular Drug Delivery Sales Market Share by Company (3015-3030)
9.2 Japan Ocular Drug Delivery Sales Market Share by Type (2015-2020)
9.3 Japan Ocular Drug Delivery Sales Market Share by Application (2015-2020)
10 Southeast Asia Ocular Drug Delivery Market Facts & Figures
10.1 Southeast Asia Ocular Drug Delivery Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Ocular Drug Delivery Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Ocular Drug Delivery Sales Market Share by Application (2015-2020)
11 India Ocular Drug Delivery Market Facts & Figures
11.1 India Ocular Drug Delivery Sales Market Share by Company (2015-2020)
11.2 India Ocular Drug Delivery Sales Market Share by Type (2015-2020)
11.3 India Ocular Drug Delivery Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Ocular Drug Delivery Business
12.1 OCULAR THERAPEUTIX, INC
12.1.1 OCULAR THERAPEUTIX, INC Corporation Information
12.1.2 OCULAR THERAPEUTIX, INC Business Overview
12.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
12.1.5 OCULAR THERAPEUTIX, INC Recent Development
12.2 Alimera Sciences
12.2.1 Alimera Sciences Corporation Information
12.2.2 Alimera Sciences Business Overview
12.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
12.2.5 Alimera Sciences Recent Development
12.3 Allergan, Plc
12.3.1 Allergan, Plc Corporation Information
12.3.2 Allergan, Plc Business Overview
12.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
12.3.5 Allergan, Plc Recent Development
12.4 EyeGate Pharma
12.4.1 EyeGate Pharma Corporation Information
12.4.2 EyeGate Pharma Business Overview
12.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
12.4.5 EyeGate Pharma Recent Development
12.5 Valeant Pharmaceuticals International, Inc
12.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
12.5.2 Valeant Pharmaceuticals International, Inc Business Overview
12.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
12.5.5 Valeant Pharmaceuticals International, Inc Recent Development
12.6 Envisia Therapeutics
12.6.1 Envisia Therapeutics Corporation Information
12.6.2 Envisia Therapeutics Business Overview
12.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
12.6.5 Envisia Therapeutics Recent Development
12.7 Clearside Biomedical
12.7.1 Clearside Biomedical Corporation Information
12.7.2 Clearside Biomedical Business Overview
12.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
12.7.5 Clearside Biomedical Recent Development
12.8 Graybug Vision Inc
12.8.1 Graybug Vision Inc Corporation Information
12.8.2 Graybug Vision Inc Business Overview
12.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
12.8.5 Graybug Vision Inc Recent Development
12.9 Taiwan Liposome Company
12.9.1 Taiwan Liposome Company Corporation Information
12.9.2 Taiwan Liposome Company Business Overview
12.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
12.9.5 Taiwan Liposome Company Recent Development
12.10 Santen Pharmaceutical
12.10.1 Santen Pharmaceutical Corporation Information
12.10.2 Santen Pharmaceutical Business Overview
12.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
12.10.5 Santen Pharmaceutical Recent Development
13 Ocular Drug Delivery Manufacturing Cost Analysis
13.1 Ocular Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Ocular Drug Delivery
13.4 Ocular Drug Delivery Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Ocular Drug Delivery Distributors List
14.3 Ocular Drug Delivery Customers
15 Market Dynamics
15.1 Ocular Drug Delivery Market Trends
15.2 Ocular Drug Delivery Opportunities and Drivers
15.3 Ocular Drug Delivery Market Challenges
15.4 Ocular Drug Delivery Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Ocular Drug Delivery Sales (K Doses) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Ocular Drug Delivery Sales (K Doses) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Ocular Drug Delivery Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Ocular Drug Delivery Sales (K Doses) by Region (2015-2020)
Table 5. Global Ocular Drug Delivery Sales Market Share by Region (2015-2020)
Table 6. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Ocular Drug Delivery Revenue Share by Region (2015-2020)
Table 8. Global Ocular Drug Delivery Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Ocular Drug Delivery Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Ocular Drug Delivery Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Ocular Drug Delivery Revenue Share Forecast by Region (2021-2026)
Table 12. Global Ocular Drug Delivery (K Doses) of Key Companies (2015-2020)
Table 13. Global Ocular Drug Delivery Sales Share by Company (2015-2020)
Table 14. Global Ocular Drug Delivery Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Ocular Drug Delivery Revenue Share by Company (2015-2020)
Table 16. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Drug Delivery as of 2019)
Table 17. Global Ocular Drug Delivery Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Ocular Drug Delivery Manufacturing Sites and Area Served
Table 19. Manufacturers Ocular Drug Delivery Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Ocular Drug Delivery Players
Table 22. Global Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 23. Global Ocular Drug Delivery Sales Share by Type (2015-2020)
Table 24. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Ocular Drug Delivery Price (K Doses) by Type (2015-2020)
Table 26. Global Ocular Drug Delivery Sales Share by Type (2021-2026)
Table 27. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Ocular Drug Delivery Revenue Share by Type (2021-2026)
Table 29. Global Ocular Drug Delivery Price (K Doses) by Type (2021-2026)
Table 30. Global Ocular Drug Delivery Sales (K Doses) by Application (2015-2020)
Table 31. Global Ocular Drug Delivery Sales Share by Application (2015-2020)
Table 32. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Ocular Drug Delivery Price (K Doses) by Application (2015-2020)
Table 34. Global Ocular Drug Delivery Sales (K Doses) by Application (2021-2026)
Table 35. Global Ocular Drug Delivery Sales Share by Application (2021-2026)
Table 36. Global Ocular Drug Delivery Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Ocular Drug Delivery Revenue Share by Application (2021-2026)
Table 38. Global Ocular Drug Delivery Price (K Doses) by Application (2021-2026)
Table 39. United States Ocular Drug Delivery Sales (K Doses) by Company (2015-2020)
Table 40. United States Ocular Drug Delivery Sales Market Share by Company (2015-2020)
Table 41. United States Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 42. United States Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 43. United States Ocular Drug Delivery Sales (K Doses) by Application (2015-2020)
Table 44. United States Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 45. Europe Ocular Drug Delivery Sales (K Doses) by Company (2015-2020)
Table 46. Europe Ocular Drug Delivery Sales Market Share by Company (2015-2020)
Table 47. Europe Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 48. Europe Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 49. Europe Ocular Drug Delivery Sales (K Doses) by Application (2015-2020)
Table 50. Europe Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 51. China Ocular Drug Delivery Sales (K Doses) by Company (2015-2020)
Table 52. China Ocular Drug Delivery Sales Market Share by Company (2015-2020)
Table 53. China Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 54. China Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 55. China Ocular Drug Delivery Sales (K Doses) by Application (2015-2020)
Table 56. China Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 57. Japan Ocular Drug Delivery Sales (K Doses) by Company (2015-2020)
Table 58. Japan Ocular Drug Delivery Sales Market Share by Company (2015-2020)
Table 59. Japan Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 60. Japan Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 61. Japan Ocular Drug Delivery Sales (K Doses) by Application (2015-2020)
Table 62. Japan Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Ocular Drug Delivery Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Ocular Drug Delivery Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 69. India Ocular Drug Delivery Sales (K Doses) by Company (2015-2020)
Table 70. India Ocular Drug Delivery Sales Market Share by Company (2015-2020)
Table 71. India Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)
Table 72. India Ocular Drug Delivery Sales Market Share by Type (2015-2020)
Table 73. India Ocular Drug Delivery Sales (K Doses) by Application (2015-2020)
Table 74. India Ocular Drug Delivery Sales Market Share by Application (2015-2020)
Table 75. OCULAR THERAPEUTIX, INC Corporation Information
Table 76. OCULAR THERAPEUTIX, INC Description and Business Overview
Table 77. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product
Table 79. OCULAR THERAPEUTIX, INC Recent Development
Table 80. Alimera Sciences Corporation Information
Table 81. Alimera Sciences Description and Business Overview
Table 82. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Alimera Sciences Ocular Drug Delivery Product
Table 84. Alimera Sciences Recent Development
Table 85. Allergan, Plc Corporation Information
Table 86. Allergan, Plc Description and Business Overview
Table 87. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Allergan, Plc Ocular Drug Delivery Product
Table 89. Allergan, Plc Recent Development
Table 90. EyeGate Pharma Corporation Information
Table 91. EyeGate Pharma Description and Business Overview
Table 92. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. EyeGate Pharma Ocular Drug Delivery Product
Table 94. EyeGate Pharma Recent Development
Table 95. Valeant Pharmaceuticals International, Inc Corporation Information
Table 96. Valeant Pharmaceuticals International, Inc Description and Business Overview
Table 97. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product
Table 99. Valeant Pharmaceuticals International, Inc Recent Development
Table 100. Envisia Therapeutics Corporation Information
Table 101. Envisia Therapeutics Description and Business Overview
Table 102. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Envisia Therapeutics Ocular Drug Delivery Product
Table 104. Envisia Therapeutics Recent Development
Table 105. Clearside Biomedical Corporation Information
Table 106. Clearside Biomedical Description and Business Overview
Table 107. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Clearside Biomedical Ocular Drug Delivery Product
Table 109. Clearside Biomedical Recent Development
Table 110. Graybug Vision Inc Corporation Information
Table 111. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Graybug Vision Inc Description and Business Overview
Table 113. Graybug Vision Inc Ocular Drug Delivery Product
Table 114. Graybug Vision Inc Recent Development
Table 115. Taiwan Liposome Company Corporation Information
Table 116. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Taiwan Liposome Company Description and Business Overview
Table 118. Taiwan Liposome Company Ocular Drug Delivery Product
Table 119. Taiwan Liposome Company Recent Development
Table 120. Santen Pharmaceutical Corporation Information
Table 121. Santen Pharmaceutical Description and Business Overview
Table 122. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Santen Pharmaceutical Ocular Drug Delivery Product
Table 124. Santen Pharmaceutical Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Ocular Drug Delivery Distributors List
Table 128. Ocular Drug Delivery Customers List
Table 129. Ocular Drug Delivery Market Key Trends
Table 130. Ocular Drug Delivery Key Opportunities and Drivers
Table 131. Ocular Drug Delivery Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Ocular Drug Delivery Product Picture
Figure 2. Global Ocular Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Ocular Drug Delivery Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Ambulatory Surgical Centers Examples
Figure 8. Ophthalmic Clinics Examples
Figure 9. Homecare Settings Examples
Figure 10. Global Ocular Drug Delivery Sales (K Doses) Growth Rate (2015-2026)
Figure 11. Global Ocular Drug Delivery Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Ocular Drug Delivery Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 13. Global Ocular Drug Delivery Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Ocular Drug Delivery Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Ocular Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Ocular Drug Delivery Sales (K Doses) Growth Rate (2015-2026)
Figure 17. Europe Ocular Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Ocular Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Ocular Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Ocular Drug Delivery Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Ocular Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Ocular Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Ocular Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Ocular Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Ocular Drug Delivery Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Ocular Drug Delivery Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Ocular Drug Delivery Players Market Share by Revenue in Ocular Drug Delivery 2015 & 2019
Figure 28. Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Ocular Drug Delivery Revenue Share by Type (2015-2020)
Figure 30. Global Ocular Drug Delivery Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Ocular Drug Delivery Revenue Share by Application (2015-2020)
Figure 32. Global Ocular Drug Delivery Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 34. United States Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 35. Europe Ocular Drug Delivery Sales Market Share by Company in 2019
Figure 36. Europe Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 37. Europe Ocular Drug Delivery Sales Market Share by Application in 2019
Figure 38. China Ocular Drug Delivery Sales Market Share by Company in 2019
Figure 39. China Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 40. China Ocular Drug Delivery Sales Market Share by Application in 2019
Figure 41. Japan Ocular Drug Delivery Sales Market Share by Company in 2019
Figure 42. Japan Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 43. Japan Ocular Drug Delivery Sales Market Share by Application in 2019
Figure 44. Southeast Asia Ocular Drug Delivery Sales Market Share by Company in 2019
Figure 45. Southeast Asia Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 46. Southeast Asia Ocular Drug Delivery Sales Market Share by Application in 2019
Figure 47. India Ocular Drug Delivery Sales Market Share by Company in 2019
Figure 48. India Ocular Drug Delivery Sales Market Share by Type in 2019
Figure 49. India Ocular Drug Delivery Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Ocular Drug Delivery
Figure 52. Manufacturing Process Analysis of Ocular Drug Delivery
Figure 53. Ocular Drug Delivery Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed